| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | dacarbazine | CTRPv2 | pan-cancer | AAC | -0.0059 | 0.9 |
| mRNA | NVP-BEZ235 | CTRPv2 | pan-cancer | AAC | 0.0077 | 0.9 |
| mRNA | CIL70 | CTRPv2 | pan-cancer | AAC | -0.0087 | 0.9 |
| mRNA | ifosfamide | CTRPv2 | pan-cancer | AAC | 0.0095 | 0.9 |
| mRNA | ISOX | CTRPv2 | pan-cancer | AAC | -0.0057 | 0.9 |
| mRNA | CIL55A | CTRPv2 | pan-cancer | AAC | -0.0088 | 0.9 |
| mRNA | thalidomide | CTRPv2 | pan-cancer | AAC | 0.0094 | 0.9 |
| mRNA | JQ-1:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0056 | 0.9 |
| mRNA | bendamustine | CTRPv2 | pan-cancer | AAC | -0.0065 | 0.9 |
| mRNA | NSC 74859 | CTRPv2 | pan-cancer | AAC | -0.0065 | 0.9 |